| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.06 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.36 | 0.06 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.058 | 0.06 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |